Navigation Links
Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
Date:4/11/2011

WHITEHOUSE STATION, N.J., and VIENNA, April 11, 2011 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) recommended suspension of enrollment. Although the trial did not meet the pre-specified futility criteria, the DMC nonetheless recommended suspension of enrollment pending further analyses of the benefit/risk profile of the vaccine candidate. Merck and Intercell plan to provide a further update when analyses have been completed.

About S. aureus

S. aureus is a leading cause of hospital-acquired infections. In addition to bloodstream infections with a mortality rate of up to 35 percent, infections of bone, heart and other inner organs can often lead to serious health complications and death. Today, approximately 50 percent of S. aureus strains isolated in hospitals worldwide are resistant to multiple antibiotics, rendering staphylococcal disease management increasingly difficult and challenging.

This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG and its business, including words such as "could," "should," "may," "expects," "anticipates," "believes," "intends," "estimates," or similar words. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Intercell AG is providing this comm
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Raises Target Price to $3.22
2. Delcath to Update Investors on FDA Meeting
3. TPI Business and Development Profile Updated on OneMedDatabase
4. Dipexium Pharmaceuticals Updates Locilex™ Development Activities and Announces 2011 Milestones
5. NeoStem Provides Results for 2010 and an Update on Recent Activities
6. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
7. Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2010 and to Provide a Business Update
9. Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
10. NewCardio to Conduct Corporate Update Conference Call on March 29, 2011
11. OXIS International to Hold Business Update Conference Call on March 22
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ORLANDO, Fla. , June 2, 2015  One ... Master of Science in Nurse Anesthesia (MSNA) graduates of ... on their first attempt. The graduating class was composed ... 20, 2015.  The NCE is required ... Registered Nurse Anesthetist, and graduates of the MSNA program ...
(Date:6/2/2015)... June 2, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... received approval from the U.S. Food and Drug Administration ... Oxycodone Hydrochloride Oral Solution 5mg/5mL. Trailing twelve-month sales for ... three current competitors. ANI expects to begin shipping to ... , President and CEO of ANI Pharmaceuticals, stated, "This ...
(Date:6/2/2015)... San MediTech, the industry leader in ... for diabetics, announced its plan to attend the American ... Boston on June 5 th to ... Monitoring System (DGMS). The company plans to show industry ... technologies and advancements made by Chinese medical device companies. ...
Breaking Medicine Technology:ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4
... Dec. 17 A leading cancer physician and,researcher ... network specializing in Phase I - Phase IV ... trial conducted to,increase pathologic complete response (pCR) and ... subsequent pCR for patients with,stage 2 and 3 ...
... SuperGen, Inc.,(Nasdaq: SUPG ) today ... in a multi-arm Phase 1b clinical trial ... inhibitor (TKI). The trial will evaluate,MP470 in ... regimens,including carboplatin/paclitaxel, carboplatin/etoposide, docetaxel,topotecan, and erlotinib. The ...
Cached Medicine Technology:US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 2US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 3US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 4SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 3
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low ... two new products implementing the ANT+ Fitness Equipment Control ... interoperability in their bike trainer products, built to create ... implemented the FE-C device profile in its Vortex Smart ... new indoor training software, while Kinomap has added FE-C ...
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
(Date:6/2/2015)... 2015 Though almost the entire Park family ... the disease rule their lives. Organizing and hosting the June ... living life to the fullest and spreading awareness of HHT. ... but I won't live my life in a bubble because ... you'd want is to look back on your life with ...
(Date:6/2/2015)... BC (PRWEB) June 02, 2015 ... report by iData Research ( http://www.idataresearch.com ), the ... and demineralized bone matrices (DBM) over traditional allograft ... two incisions and thus an increase in operation ... The strong market growth in these synthetic materials ...
(Date:6/2/2015)... Williamsport, PA (PRWEB) June 02, 2015 ... Survey indicate that while there has been a ... (e-cigarettes) has tripled and waterpipe vapor (hookah) usage has ... Health Pediatrician Dr. Russell Gombosi believes the national ... that it could take 15 to 20 years to ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3
... More and ... Milk Their Diets, BIRMINGHAM, Ala., Aug. 22 The ... -- which seem to go in,and out of fashion like shoulder pads and ... 25 percent of,Alabama residents -- remain overweight or obese., A new campaign ...
... to Lead Effort to End Malaria Deaths, NEW ... to raise awareness and galvanize support to address the ... Case to the,post of Chief Executive Officer, effective immediately. ... of Malaria No More in December 2006,has served as ...
... 22 Corbett Accel Healthcare Group (CAHG),is proud ... Executive Vice,President, Interactive Marketing & eInnovation, Corbett Accel ... become a member of the Executive,Leadership Team of ... a,leading digital interactive communications agency. Melick is based ...
... -, FREMONT, Calif., Aug. 22 Vermillion, ... announced the publication,of data supporting its peripheral artery ... the August, 2008 issue of the peer-reviewed,journal, Vascular ... MD, PhD,Professor of Medicine at Stanford University and ...
... launch the most sophisticated mission ever to investigate the ... of our planet the geoid - with unprecedented ... Ocean Circulation Explorer (GOCE) will be placed onto a ... vehicle launched from the Plesetsk Cosmodrome in Northern Russia, ...
... of cancer-causing compounds , , FRIDAY, Aug. 22 (HealthDay News) ... too, without producing harmful cancer-causing compounds, new research shows. ... antioxidant-rich spice blends can reduce the risk of these ... , "If you are concerned about carcinogens, marinating a ...
Cached Medicine News:Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Malaria No More Names Scott Case Chief Executive Officer 2Health News:Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation 2Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 3Health News:GOCE Earth explorer satellite to look at the Earth's surface and core 2Health News:Marinades Help Keep Grilled Meat Safe 2Health News:Marinades Help Keep Grilled Meat Safe 3
Round handle dull finish. For right handed surgeon....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand....
Irrigating nucleus chopper, 0.6 mm dual sideports, 20 gauge. For the right handed surgeon....
Medicine Products: